Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases

NCT05484583 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Extensive-stage Small-cell Lung Cancer
Radiotherapy

Interventions

DRUG: Durvalumab + carboplatin/cisplatin + etoposide
RADIATION: Consolidation radiotherapy
DRUG: Durvalumab

Sponsor

Affiliated Cancer Hospital & Institute of Guangzhou Medical University